Running head: auger biotech ipo essay

Leadership development at Gene One has not been a priority in the organization. Execute an initial public. Table 1 depicts several key issues and opportunities for Gene One. The opportunity is to increase the number of clinical trials and viable research projects. Gene One is a privately held biotech company that is planning to go public in the next 36 months.

Table 2 depicts several conflicts between individuals on the management team. Ruiz will provide a plan that addresses all the stakeholder groups that includes a shared organizational vision and a roadmap for success.

Raising funds for the IPO and the fast paced technological changes in the biotech industry are external issues. A leadership development program will provide a roadmap for the new corporate culture.

The management team has conflicting goals for the company and this is causing leadership issues with several officers and board members. Some leaders may leave while others will embrace the new company.

The organizational culture has not grown as fast as the products and profits of the company. There are many issues and opportunities that will arise for Gene One during the implementation of the plan.

By implementing this plan, the Board and Wall Street will feel comfortable that the issues related to the IPO are being addressed and that future profitability of the organization becomes a top priority.

The implementation of the marketing infrastructure will provide a methodology to bring new products to market.

The desired future end state goals are: There are two glaring external issues for Gene One to deal with while implementing the plan. By focusing on these topics sufficient knowledge will be gained to make informed decisions regarding alternatives for Gene One.

Running Head: Auger Biotech IPO Essay Sample

Describe the Situation Issue and Opportunity Identification Gene One is an organization that is in transition and is in need of transformational leadership. McShane and Von Glinow describe transformational leadership as a leadership perspective that explains how leaders such as the CEO of Gene One can change the organization by creating, communicating, and modeling a vision for that organization and inspiring employees to strive towards the vision.

Introduction Gene One is at a crossroad as an organization. The opportunity is the development of a high performing culture working towards a common goal.

The conflict between leadership and the research team will be addressed by the development of a research strategic plan. Leadership will be much more comfortable when the IPO expert arrives and can answer questions and lead the IPO transformation from a private to a public company.

They have moved quickly from a small start-up to a company that needs to go public to attract additional investment and capital to fund the new products, staffing, and innovations.

I will address the issues and opportunities in the next few paragraphs. The data received from this research was extremely valuable to Gene One. The internal issues focus on IPO preparation, lack of knowledge regarding IPO, and personal conflicts and attitudes within management.

Identify the Alternatives and Benchmarking Validation Gene One conducted benchmarking to develop alternative solutions to the end state goals. Describe the Situation Issue and Opportunity Identification Gene One is strategically planning to go public within the next 36 months.

The solution will test the values, ethics and emotions of the leaders of the organization. The benchmarking focused on many topics such as expanding market territory, the biotech industry, GAAP, leadership competency, and companies that had successfully and unsuccessfully applied for IPO.

Gene One The next three years will be either extremely devastating or profitable to Gene One. The research on expanding market territory indicated that Gene One should increase customer base. Don Ruiz, the CEO must provide transformational leadership competencies to lead the organization through this difficult time.

As the company grows, leadership development is a key component to improved job satisfaction and work behavior. They must also develop their potential through leadership development programs and practical experience in the field. The plan features a research strategic plan, IPO expertise, a leadership development program, and a marketing infrastructure.

By going public Gene One can increase the profits, product knowledge, market share, and develop a cohesive management team. The opportunities are vast for Gene One.

The competency perspective of leadership states that leaders become effective only after they have developed and mastered the necessary leadership competencies McShane and Von Glinow, Gene One Problem Solution: The issue is that good research cannot be rushed.Gene One is a privately held biotech company that is planning to go public in the next 36 months.

Wall Street is optimistic the biotech industry will grow exponentially and Gene One is confident they can increase profits based on the products being developed by the R&D organization.

Running head: PROBLEM SOLUTION: GENE ONE Problem Solution for Gene One University of Phoenix MBA – Transformational Leadership Problem Solution for Gene One Change is inevitable in any organization; however, there are a myriad of approaches toward that change and the individuals involved.

GeneOne is a biotech company that wants to grow. The market is showing favorable conditions to enter the public sector.

The market is showing favorable conditions to enter the public sector. The research and development departments. View Essay - The Future of Biotech Health and Life ultimedescente.com from BMGT at University of Maryland, University College.

RUNNING HEAD: THE FUTURE OF BIOTECH HEALTH AND LIFE PRODUCTS, Find Study Resources. RUNNING HEAD: THE FUTURE OF BIOTECH HEALTH AND LIFE PRODUCTS, INC%(47).

Running Head: Article Analysis Article Analysis Amysue Raburn Professor Stair December 15, The article Head: Article Analysis Article Analysis Amysue Raburn Professor Stair December 15, The article. Running Head: Amgen Inc., NASDAQ, AMGN 2 AMGen Inc. Introduction: By providing quality service for the need of patients, Amgen has earned its way on the Fortune list.

Amgen's success is driven to seek power to strengthen health or save lives. Amgen values contribute to the company being the greatest biotech company%(1).

Download
Running head: auger biotech ipo essay
Rated 5/5 based on 82 review